Skip to main content

Indication for Peripheral Intravenous Catheterisation

0
Pipeline Programs
1
Companies
2
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Becton Dickinson
Becton DickinsonFRANKLIN LAKES, NJ
1 program
Peripheral Intravenous CatheterN/A2 trials
Active Trials
NCT07779317Recruiting292Est. Mar 2027
NCT04344314Completed40Est. Mar 2021

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
Becton DickinsonPeripheral Intravenous Catheter
Becton DickinsonPeripheral Intravenous Catheter

Clinical Trials (2)

Total enrollment: 332 patients across 2 trials

NCT07779317Becton DickinsonPeripheral Intravenous Catheter

Single Lumen Midline Catheter vs Ultrasound Guided Peripheral IV as Performed by Bedside Emergency Department Registered Nurses

Start: Aug 2026Est. completion: Mar 2027292 patients
N/ARecruiting
NCT04344314Becton DickinsonPeripheral Intravenous Catheter

Impact of PIVC Length and Gauge on Catheter Indwell Time

Start: Aug 2020Est. completion: Mar 202140 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 332 patients
1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.